Search

The Clinical Core serves as the hub for all activities of the North Texas Alzheimer’s Disease Research Center (NT-ADRC) and affiliated investigators.

webpage for current research administrators at UT Southwestern Anesthesiology Department

Accredited Continuing Education Welcome! Advance your expertise through a comprehensive portfolio of accredited continuing education opportunities at UT Southwestern. Here, you’ll find a blend of on-demand learning through our archived offerings (many which are eligible for self-study CE credit) as w…

Researchers at UT Southwestern Medical Center have developed a computational method that reveals how immune cells navigate the complex environment inside tumors, offering insights that could inform future cancer therapies.

Treating glioblastoma with a class of drugs known as EGFR inhibitors made this cancer more sensitive to chemotherapy, suggests a study in preclinical models co-led by researchers at UT Southwestern Medical Center and the University of Alabama at Birmingham.

The Data Management, Informatics, and Statistics Core of the North Texas Alzheimer’s Disease Research Center is a hub for data collection and dissemination.

Past Community Engagement Events

The Neuropathology Core of the NT-ADRC seeks to characterize and document the structural neuropathologic features of Alzheimer’s disease and related disorders.

The Administrative Core will oversee the North Texas Alzheimer’s Disease Research Center’s (NT-ADRC) activities to achieve its mission.

Belzutifan, a first-in-class drug that arose from scientific discoveries at UT Southwestern Medical Center, has been approved by the Food and Drug Administration to treat some patients with earlier stage kidney cancers in combination with an immunotherapy drug.